SEC Form 4 · accession 0001209191-18-038597
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Baiju R. Shah
Director
Period of report
Jun 15, 2018
Accepted (ET)
Jun 19, 2018 · 4:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF2 | Jun 15, 2018 | S | 4,000 | $19.65 | D | 42,941 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4,F3 | — | holding | — | — | — | — | — | Common Shares | 4,496 | 4,496 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2Includes 15,314 previously reported restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan. 8,606 of these restricted stock units vested in full on May 15, 2018; however, the reporting person has elected to defer receipt of the common shares issuable upon the vesting of these restricted stock units until the earlier of January 1, 2027 or his separation from the issuer, pursuant to the Invacare Corporation 2012 Non-Employee Directors Deferred Compensation Plan. 6,708 of these restricted stock units vest in full on May 15, 2019; however, the reporting person has elected to defer receipt of the common shares issuable upon vesting of these restricted stock units until the earlier of January 1, 2027 or his separation from the issuer, pursuant to the 2012 Invacare Corporation Non-Employee Directors Deferred Compensation Plan.
- F3No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- F4The reporting person holds previously reported options to buy 4,496 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on May 19, 2011, at an exercise price of $33.36 per share, will expire on May 19, 2021, and became exercisable between March 31, 2012 and March 31, 2015.